Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02351037
Title A Multicenter Open-Label Phase 2a Study of Ibrutinib With or Without Cytarabine in Subjects With Acute Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Pharmacyclics
Indications

acute myeloid leukemia

Therapies

Ibrutinib

Cytarabine

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
UC Davis Medical Center Sacramento California 95817 United States Details
The University of Chicago Medical Center Chicago Illinois 60637 United States Details
University of Iowa Iowa City Iowa 52242 United States Details
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231 United States Details
Montefiore Einstein Center for Cancer Research Bronx New York 10461 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Fred Hutchinson Cancer Research Center Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field